| Financial Year |
March 31 2023 |
| Monetary Funds |
1,064,714,259.40 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
828,590,249.43 |
| Accounts Receivable |
1,460,237,716.69 |
| Advances to Suppliers |
144,204,298.94 |
| Other Receivables |
15,619,217.44 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
730,581,803.52 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
80,204,801.36 |
| Total Current Assets |
4,324,152,346.78 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
2,438,027.73 |
| Fixed Assetes |
1,478,697,662.59 |
| Under-construction Projects |
201,099,095.96 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
162,033,593.00 |
| R&D expenses |
-- |
| Goodwill |
185,289,590.07 |
| Long-Term Deferred and Prepaid Expenses |
854,533.94 |
| Deferred Income Tax Assets |
9,616,895.20 |
| Other Non-Current Assets |
10,349,095.63 |
| Sub-Total of Non-Current Assets |
2,050,378,494.12 |
| Total Assets |
6,374,530,840.90 |
| Short-Term Loans |
604,452,453.21 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,379,251,902.54 |
| Accounts Payable |
826,921,526.95 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
28,260,322.42 |
| Taxes Payable |
20,246,986.60 |
| Interest Payable |
-- |
| Dividend Payable |
200,000,000.00 |
| Other payables |
483,597,294.67 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
35,570,000.00 |
| Other Current Liabilities |
3,156,836.82 |
| Sub-Total of Current Liabilities |
3,408,879,848.69 |
| Long-term Loans |
349,096,430.03 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
485,599,756.57 |
| Total Liabilities |
3,894,479,605.26 |
| Paid-In Capital(Or Share Stock) |
622,166,300.00 |
| Capital Surplus |
1,092,170,483.83 |
| Surplus Reserve |
7,666,645.24 |
| LESS:Treasury Stock |
33,623,530.00 |
| Undistributed Profits |
737,479,396.74 |
| Minority Stockholder's Interest |
55,102,138.90 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,424,949,096.74 |
| Owner's Equity（Stockholder's Equity） |
2,480,051,235.64 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,374,530,840.90 |
